0001209191-21-022928.txt : 20210324
0001209191-21-022928.hdr.sgml : 20210324
20210324181823
ACCESSION NUMBER: 0001209191-21-022928
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201209
FILED AS OF DATE: 20210324
DATE AS OF CHANGE: 20210324
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GARDINER SANDRA A.
CENTRAL INDEX KEY: 0001218574
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37744
FILM NUMBER: 21769457
MAIL ADDRESS:
STREET 1: CUTERA, INC.
STREET 2: 3240 BAYSHORE BOULEVARD
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER NAME:
FORMER CONFORMED NAME: GARDINER SANDRA
DATE OF NAME CHANGE: 20030212
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pulse Biosciences, Inc.
CENTRAL INDEX KEY: 0001625101
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 465696597
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3957 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
BUSINESS PHONE: 510-906-4600
MAIL ADDRESS:
STREET 1: 3957 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
FORMER COMPANY:
FORMER CONFORMED NAME: Electroblate, Inc.
DATE OF NAME CHANGE: 20141113
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-09
0
0001625101
Pulse Biosciences, Inc.
PLSE
0001218574
GARDINER SANDRA A.
3957 POINT EDEN WAY
HAYWARD
CA
94545
0
1
0
0
CFO & EVP Admin. and Finance
Stock Option (right to buy)
13.94
2020-12-09
4
A
0
25961
0.00
A
2029-11-18
Common Stock
25961
25961
D
Stock Option (right to buy)
10.66
2021-02-23
4
A
0
8750
0.00
A
2030-05-18
Common Stock
8750
8750
D
Stock Option (right to buy)
24.03
2021-03-22
4
A
0
18000
0.00
A
2022-03-01
2031-03-22
Common Stock
18000
18000
D
Represents the acquisition of vested options upon the determination of the Compensation Committee of the Board of Directors of the Issuer that certain performance conditions were met with respect to performance-based stock options granted to the Reporting Person on November 18, 2019.
Represents the acquisition of vested options upon the determination of the Compensation Committee of the Board of Directors of the Issuer that certain performance conditions were met in 2020 with respect to performance-based stock options granted to the Reporting Person on May 18, 2020.
The shares subject to the option will vest in equal annual installments over the following four years on the anniversary of March 1, 2021, subject to the Reporting Person's continued service through each vesting date.
/s/ Sandra Gardiner
2021-03-24